» Articles » PMID: 2950265

Significance of Suppressor Macrophages for Immunosurveillance of Tumor-bearing Mice

Overview
Specialty Oncology
Date 1987 Mar 1
PMID 2950265
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The in vivo significance of suppressor macrophages for antitumor immunity was investigated in a syngeneic tumor system. The presence of suppressor macrophages in the spleens of X5563 C3H/HeN tumor-bearing mice (TBM) was directly shown in vitro. Thus the addition of splenic macrophages of TBM suppressed the in vitro secondary induction of both tumor-specific cytotoxic T-cells and effector cells of the delayed-type hypersensitivity reaction. Splenic macrophages of TBM exerted suppression on tumor-specific T-cell-mediated cytotoxicity in the effector phase as well. Prostaglandin production was found to be one of the major mechanisms involved in macrophage-induced suppression. In vivo treatment of TBM with carrageenan and/or indomethacin retarded tumor growth and in parallel augmented cell-mediated cytotoxicity against X5563 cells, probably by affecting suppressor macrophages in vivo. The suppressive effect of splenic macrophages from TBM was clearly demonstrated in a tumor-neutralization test indicating that suppressor macrophages were able to exert their function in vivo as well as in vitro. All these results suggested that suppressor macrophages had in vivo significance for the suppression of the immunosurveillance of the hosts.

Citing Articles

Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro.

Schebesch C, Kodelja V, Muller C, Hakij N, Bisson S, Orfanos C Immunology. 1998; 92(4):478-86.

PMID: 9497489 PMC: 1364153. DOI: 10.1046/j.1365-2567.1997.00371.x.


Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses.

Otsuji M, Kimura Y, Aoe T, Okamoto Y, Saito T Proc Natl Acad Sci U S A. 1996; 93(23):13119-24.

PMID: 8917554 PMC: 24056. DOI: 10.1073/pnas.93.23.13119.


Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules.

Kiessling R, Kono K, Petersson M, Wasserman K Springer Semin Immunopathol. 1996; 18(2):227-42.

PMID: 8908702 DOI: 10.1007/BF00820668.


Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state.

Fujiwara H, Hamaoka T Immunol Res. 1995; 14(4):271-91.

PMID: 8722044 DOI: 10.1007/BF02935625.


Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.

Li X, Takiuchi H, Zou J, Katagiri T, Yamamoto N, Nagata T Jpn J Cancer Res. 1993; 84(3):315-25.

PMID: 8098027 PMC: 5919158. DOI: 10.1111/j.1349-7006.1993.tb02873.x.